Ashley Brissette, MD
Ophthalmology · New York, NYNPI 1366802951
Payments from drug & device makers
Across 384 payments — averaging $1177.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon Research LLC$177K
- Alcon$98K
- Sun Pharmaceutical Industries Inc.$82K
- Carl Zeiss Meditec, Inc.$19K
- Bausch & Lomb Americas Inc.$18K
- Novartis$8K
- plus $49K from 24 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon Research LLC | 19 | $176,575 |
| Alcon | 98 | $98,181 |
| Sun Pharmaceutical Industries Inc. | 78 | $82,433 |
| Carl Zeiss Meditec, Inc. | 17 | $19,201 |
| Bausch & Lomb Americas Inc. | 18 | $18,031 |
| Novartis | 17 | $8,411 |
| Lumenis BE Inc | 1 | $8,221 |
| Johnson & Johnson Surgical Vision, Inc. | 16 | $7,582 |
| AbbVie(2 entities) | 14 | $7,181 |
| Tarsus Pharmaceuticals, Inc. | 20 | $5,373 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 2 | $4,100 |
| Eyevance Pharmaceuticals LLC | 6 | $3,519 |
| Dompe US, Inc. | 13 | $2,529 |
| Ocular Therapeutix, Inc. | 4 | $2,191 |
| Quidel Corporation | 4 | $1,579 |
| Tearlab Corp | 2 | $1,325 |
| Kala Pharmaceuticals, Inc. | 6 | $1,300 |
| Glaukos Corporation | 3 | $1,178 |
| Harrow Eye, LLC | 16 | $847 |
| Oyster Point Pharma, Inc. | 12 | $840 |
| Sight Sciences, Inc. | 4 | $423 |
| Rxsight Inc | 2 | $234 |
| Eyepoint US, Inc. | 2 | $232 |
| Shire North American Group Inc | 2 | $197 |
| Amgen | 2 | $157 |
| Carl Zeiss Meditec USA, Inc. | 1 | $142 |
| Omeros Corporation | 1 | $125 |
| Ortho-clinical Diagnostics, Inc. | 1 | $88 |
| Biotissue Holdings Inc. | 2 | $48 |
| Rayner Intraocular Lenses Limited | 1 | $20 |
How this compares
$452,263 in reported general payments places this provider in the 95th percentile of 1,587 ophthalmology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other ophthalmology in New York
- Douglas JabsNew York$24.3M
- Nathan RadcliffeNew York$2.4M
- Richard SpaideNew York$1.7M
- Jason SlakterNew York$1.2M
- David ChuNew York$1.2M
- Sharon KehNew York$941K
- Joshua YoungNew York$814K
- Joseph PanarelliNew York$704K
- Joshua KimNew York$677K
- Eric RosenbergNew York$526K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.